Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyling Cheok

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Blood|May 15, 2004
Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesisGianluigi Zaza, Wenjian Yang, Leo Kager, et al.
International Journal of Molecular Sciences|August 13, 2020
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia TreatmentLaurène Fenwarth, Elise Fournier, Meyling Cheok, et al.
Cancer Research|July 15, 2015
CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for TherapyNicolas Poret, Qiangwei Fu, Soizic Guihard, et al.
Ejhaem|July 18, 2022
Bimodal expression of <i>RHOH</i> during myelomonocytic differentiation: Implications for the expansion of AML differentiation therapySylvie Galiègue-Zouitina, Qiangwei Fu, Céline Carton-Latreche, et al.
The Journal of Clinical Investigation|January 5, 2005
Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamicsLeo Kager, Meyling Cheok, Wenjian Yang, et al.
Oncotarget|August 28, 2016
Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemiaThomas Boyer, Soizic Guihard, Christophe Roumier, et al.
Genes, Chromosomes & Cancer|November 16, 2004
Lymphoid gene expression as a predictor of risk of secondary brain tumorsMathew J Edick, Cheng Cheng, Wenjian Yang, et al.
The Pharmacogenomics Journal|July 15, 2025
Correction: Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicityRomain Larrue, Sandy Fellah, Benjamin Hennart, et al.
The Pharmacogenomics Journal|January 12, 2024
Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicityRomain Larrue, Sandy Fellah, Benjamin Hennart, et al.
Pharmacogenetics and Genomics|December 3, 2009
Thiopurine pathwayGianluigi Zaza, Meyling Cheok, Natalia Krynetskaia, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Blood|May 15, 2004
Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesisGianluigi Zaza, Wenjian Yang, Leo Kager, et al.
International Journal of Molecular Sciences|August 13, 2020
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia TreatmentLaurène Fenwarth, Elise Fournier, Meyling Cheok, et al.
Cancer Research|July 15, 2015
CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for TherapyNicolas Poret, Qiangwei Fu, Soizic Guihard, et al.
Ejhaem|July 18, 2022
Bimodal expression of <i>RHOH</i> during myelomonocytic differentiation: Implications for the expansion of AML differentiation therapySylvie Galiègue-Zouitina, Qiangwei Fu, Céline Carton-Latreche, et al.
The Journal of Clinical Investigation|January 5, 2005
Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamicsLeo Kager, Meyling Cheok, Wenjian Yang, et al.
Oncotarget|August 28, 2016
Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemiaThomas Boyer, Soizic Guihard, Christophe Roumier, et al.
Genes, Chromosomes & Cancer|November 16, 2004
Lymphoid gene expression as a predictor of risk of secondary brain tumorsMathew J Edick, Cheng Cheng, Wenjian Yang, et al.
The Pharmacogenomics Journal|July 15, 2025
Correction: Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicityRomain Larrue, Sandy Fellah, Benjamin Hennart, et al.
The Pharmacogenomics Journal|January 12, 2024
Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicityRomain Larrue, Sandy Fellah, Benjamin Hennart, et al.
Pharmacogenetics and Genomics|December 3, 2009
Thiopurine pathwayGianluigi Zaza, Meyling Cheok, Natalia Krynetskaia, et al.
Pageof 5